Galectin Therapeutics Stock Swing Long Chart Setup

Galectin Therapeutics stock is a completely technical play on an oversold chart setup. This is a quick swing move up gambit as the company reports Phase 2b top-line data.

Galectin Therapeutics stock looks like a compelling swing long setup on the chart. The gambit is a bounce off its 200 day moving average support.